2-aminobicyclo(2,2,1)heptane-2-carboxylic acid has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SE; Han, SJ; Kang, Y; Kim, DJ; Kim, HJ; Lee, HC; Lee, KW; Lee, SJ; Yi, SA | 1 |
| Göhring, I; Mulder, H | 1 |
2 other study(ies) available for 2-aminobicyclo(2,2,1)heptane-2-carboxylic acid and Diabetes Mellitus
| Article | Year |
|---|---|
β-Cell-protective effect of 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid as a glutamate dehydrogenase activator in db/db mice.
Topics: Amino Acids, Cyclic; Animals; Apoptosis; Blood Glucose; Cell Line, Tumor; Diabetes Mellitus; Drug Synergism; Enzyme Activation; Gene Expression; Glucose; Glutamate Dehydrogenase; Insulin; Insulin Secretion; Insulin-Secreting Cells; Insulinoma; Mice; Pancreatic Neoplasms; Rats | 2012 |
Glutamate dehydrogenase, insulin secretion, and type 2 diabetes: a new means to protect the pancreatic β-cell?
Topics: Amino Acids, Cyclic; Animals; Diabetes Mellitus; Glutamate Dehydrogenase; Insulin-Secreting Cells | 2012 |